المؤلفون: Orellana-Noia, VM, Reed, DR, McCook, AA, Sen, JM, Barlow, CM, Malecek, M-K, Watkins, M, Kahl, BS, Spinner, MA, Advani, R, Voorhees, TJ, Snow, A, Grover, NS, Ayers, A, Romancik, JT, Liu, Y, Huntington, SF, Chavez, JC, Saeed, H, Lazaryan, A, Raghunathan, V, Spurgeon, SE, Ollila, TA, Del Prete, C, Olszewski, AJ, Ayers, EC, Landsburg, DJ, Echalier, B, Lee, J, Kamdar, M, Caimi, PF, Fu, T, Liu, J, David, KA, Alharthy, H, Law, J, Karmali, R, Shah, H, Stephens, DM, Major, A, Rojek, AE, Smith, SM, Yellala, A, Kallam, A, Nakhoda, S, Khan, N, Sohail, MA, Hill, BT, Barrett-Campbell, O, Lansigan, F, Switchenko, J, Cohen, JB, Portell, CA

المصدر: Blood; 20210101, Issue: Preprints

المؤلفون: Epperla N; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, United States., Zayac AS; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States., Landsburg DJ; University of Pennsylvania, Philadelphia, Pennsylvania, United States., Bock AM; Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States., Nowakowski GS; Mayo Clinic, Rochester, Minnesota, United States., Ayers EC; University of Virginia, Charlottesville, Virginia, United States., Girton MR; University of Michigan School of Medicine, Ann Arbor, Michigan, United States., Hu M; University of Minnesota, Minneapolis, Minnesota, United States., Beckman AK; University of Minnesota, Minneapolis, Minnesota, United States., Li S; UT MD Anderson Cancer Center, Houston, Texas, United States., Medeiros LJ; The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States., Chang JE; University of Wisconsin, Madison, Wisconsin, United States., Kurt H; Brown University, Providence, Rhode Island, United States., Sandoval-Sus J; Moffitt Cancer Center at Memorial Healthcare System, Pembroke Pines, Florida, United States., Ansari-Lari MA; Memorial Health System-Moffitt Cancer Center, Hollywood, Florida, United States., Kothari SK; Yale University, New Haven, Connecticut, United States., Kress A; Yale University, New Haven, Connecticut, United States., Xu ML; Yale University School of Medicine, New Haven, Connecticut, United States., Torka P; Memorial Sloan Kettering Cancer Center, Montvale, New Jersey, United States., Sundaram S; Mount Sinai Icahn School Of Medicine, New York, New York, United States., Smith SD; Fred Hutchinson Cancer Center, Seattle, Washington, United States., Naresh KN; Fred Hutchinson Cancer Research Center, Seattle, Washington, United States., Karimi YH; University of Michigan, Ann Arbor, Michigan, United States., Bond DA; The Ohio State University, Columbus, Ohio, United States., Evens AM; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States., Naik SG; Penn State Cancer Institute, Hershey, Pennsylvania, United States., Kamdar M; University of Colorado Cancer Center, Aurora, Colorado, United States., Haverkos BM; University of Colorado, Aurora, Colorado, United States., Karmali R; Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States., Farooq U; University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States., Vose JM; University of Nebraska Medical Center, Omaha, Nebraska, United States., Rubinstein PG; Univeristy of Illinois, Chicago, Chicago, Illinois, United States., Chaudhry A; Stanford University School of Medicine, Stanford, California, United States., Olszewski AJ; Warren Alpert Medical School of Brown University, Providence, Rhode Island, United States.

المصدر: Blood advances [Blood Adv] 2024 Aug 27. Date of Electronic Publication: 2024 Aug 27.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

المؤلفون: Zayac AS; Division of Hematology/Oncology, The Warren Alpert Medical School Medical School of Brown University, Providence, RI., Landsburg DJ; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Hughes ME; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Bock AM; Division of Hematology, Mayo Clinic, Rochester, MN., Nowakowski GS; Division of Hematology, Mayo Clinic, Rochester, MN., Ayers EC; Division of Hematology/Oncology, University of Virginia, Charlottesville, VA., Girton M; Department of Pathology, University of Virginia School of Medicine, Charlottesville, VA., Hu M; Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN., Beckman AK; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN., Li S; Division of Pathology and Laboratory Medicine, Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX., Medeiros LJ; Division of Pathology and Laboratory Medicine, Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX., Chang JE; Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI., Stepanovic A; Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI., Kurt H; Department of Pathology and Laboratory Medicine, The Warren Alpert Medical School of Brown University, Providence, RI., Sandoval-Sus J; Department of Malignant Hematology and Cellular Therapy, Moffitt Cancer Center at Memorial Healthcare System, Pembroke Pines, FL., Ansari-Lari MA; Department of Pathology, Memorial Healthcare System, Hollywood, FL., Kothari SK; Division of Hematology, Yale University School of Medicine, New Haven, CT., Kress A; Division of Hematology, Yale University School of Medicine, New Haven, CT., Xu ML; Department of Pathology and Department of Laboratory Medicine, Yale University School of Medicine, New Haven, CT., Torka P; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY., Sundaram S; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY., Smith SD; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA.; Division of Medical Oncology, University of Washington, Seattle, WA., Naresh KN; Department of Pathology, University of Washington, Seattle, WA., Karimi YH; Division of Hematology-Oncology, University of Michigan Health, Ann Arbor, MI., Epperla N; The Ohio State University Comprehensive Cancer Center, Columbus, OH., Bond DA; The Ohio State University Comprehensive Cancer Center, Columbus, OH., Farooq U; Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA., Saad M; Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA., Evens AM; Department of Medicine, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ., Pandya K; Department of Medicine, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ., Naik SG; Penn State Cancer Institute, Penn State Hershey Medical Center, Hershey, PA., Kamdar M; Division of Hematology, Hematologic Malignancies and Stem Cell Transplantation, University of Colorado, Denver, CO., Haverkos B; Division of Hematology, Hematologic Malignancies and Stem Cell Transplantation, University of Colorado, Denver, CO., Karmali R; Division of Hematology and Oncology, Northwestern University, Chicago, IL., Oh TS; Division of Hematology and Oncology, Northwestern University, Chicago, IL., Vose JM; Department of Medicine, University of Nebraska Medical Center, Omaha, NE., Nutsch H; Department of Medicine, University of Nebraska Medical Center, Omaha, NE., Rubinstein PG; Department of Medicine, Section of Hematology-Oncology, University of Illinois, Chicago, IL., Chaudhry A; Department of Medicine, Section of Hematology-Oncology, University of Illinois, Chicago, IL., Olszewski AJ; Division of Hematology/Oncology, The Warren Alpert Medical School Medical School of Brown University, Providence, RI.

المصدر: Blood advances [Blood Adv] 2023 Nov 14; Vol. 7 (21), pp. 6381-6394.

نوع المنشور: Multicenter Study; Journal Article

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma, Large B-Cell, Diffuse*/diagnosis , Lymphoma, Large B-Cell, Diffuse*/drug therapy , Lymphoma, Large B-Cell, Diffuse*/genetics, Humans ; Middle Aged ; Rituximab/therapeutic use ; Retrospective Studies ; Prednisone/therapeutic use ; Vincristine/therapeutic use ; Proto-Oncogene Proteins c-bcl-2/genetics ; Proto-Oncogene Proteins c-myc/genetics ; Cyclophosphamide/therapeutic use ; Doxorubicin/therapeutic use ; Etoposide ; Lactate Dehydrogenases

المؤلفون: Bowers JT; University of Pennsylvania Perelman School of Medicine, Philadelphia, PA., Anna J; Division of Hematology, University of Colorado Denver, Aurora, CO., Bair SM; Division of Hematology, University of Colorado Denver, Aurora, CO., Annunzio K; The Ohio State University, Columbus, OH., Epperla N; The Ohio State University, Columbus, OH., Pullukkara JJ; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL., Gaballa S; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL., Spinner MA; Division of Hematology Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA., Li S; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA., Messmer MR; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA., Nguyen J; Division of Hematology/Oncology, University of Virginia, Charlottesville, VA., Ayers EC; Division of Hematology/Oncology, University of Virginia, Charlottesville, VA., Wagner CB; Division of Hematology/Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT., Hu B; Division of Hematology/Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT., Di M; Division of Hematology Oncology, Department of Medicine, Yale University, New Haven, CT., Huntington SF; Division of Hematology Oncology, Department of Medicine, Yale University, New Haven, CT., Furqan F; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI., Shah NN; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI., Chen C; University of Pennsylvania Perelman School of Medicine, Philadelphia, PA., Ballard HJ; Division of Hematology Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA., Hughes ME; Division of Hematology Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA., Chong EA; Division of Hematology Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA., Nasta SD; Division of Hematology Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA., Barta SK; Division of Hematology Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA., Landsburg DJ; Division of Hematology Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA., Svoboda J; Division of Hematology Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA.

المصدر: Blood advances [Blood Adv] 2023 Nov 14; Vol. 7 (21), pp. 6630-6638.

نوع المنشور: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Hodgkin Disease*/complications , Hodgkin Disease*/drug therapy , Hodgkin Disease*/pathology , Peripheral Nervous System Diseases*/etiology , Peripheral Nervous System Diseases*/chemically induced, Humans ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Brentuximab Vedotin/therapeutic use ; Incidence ; Retrospective Studies

المؤلفون: Lantz J; Division of Hematology and Oncology and Comprehensive Cancer Center, Department of Medicine, University of Virginia School of Medicine; Charlottesville, VA, USA. Electronic address: Rqu4xd@uvahealth.ord., Portell CA; Division of Hematology and Oncology and Comprehensive Cancer Center, Department of Medicine, University of Virginia School of Medicine; Charlottesville, VA, USA. Electronic address: Cp4ys@uvahealth.org., Ayers EC; Division of Hematology and Oncology and Comprehensive Cancer Center, Department of Medicine, University of Virginia School of Medicine; Charlottesville, VA, USA. Electronic address: Eca2t@uvahealth.org.

المصدر: Blood reviews [Blood Rev] 2023 Sep; Vol. 61, pp. 101101. Date of Electronic Publication: 2023 May 26.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 8708558 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1681 (Electronic) Linking ISSN: 0268960X NLM ISO Abbreviation: Blood Rev Subsets: MEDLINE

مواضيع طبية MeSH: Central Nervous System Neoplasms*/drug therapy , Central Nervous System Neoplasms*/etiology , Central Nervous System Neoplasms*/prevention & control , Lymphoma, Large B-Cell, Diffuse*/drug therapy , Lymphoma, Large B-Cell, Diffuse*/pathology, Humans ; Retrospective Studies ; Prospective Studies ; Neoplasm Recurrence, Local/drug therapy ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Rituximab/therapeutic use ; Cyclophosphamide/adverse effects ; Prednisone/adverse effects ; Vincristine/adverse effects ; Central Nervous System/pathology ; Doxorubicin/adverse effects ; Recurrence

المؤلفون: Hess BT; Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina, USA., Giri A; Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA., Park Y; Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina, USA., Patel KK; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Link BK; Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, Iowa, USA., Nowakowski GS; Mayo Clinic, Rochester, Minnesota, USA., Maliske SM; Roger Maris Cancer Center Sanford Health, Fargo, North Dakota, USA., Fortin S; Mayo Clinic, Rochester, Minnesota, USA., Chavez JC; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, Florida, USA., Saeed H; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, Florida, USA., Hill BT; Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic Foundation, Cleveland, Ohio, USA., Mejia Garcia AV; Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic Foundation, Cleveland, Ohio, USA., Maddocks KJ; Division of Hematology, The Ohio State University, Columbus, Ohio, USA., Hanel W; Division of Hematology, The Ohio State University, Columbus, Ohio, USA., Wagner-Johnston ND; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital, Baltimore, Maryland, USA., Messmer MR; Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA., Kahl BS; Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri, USA., Watkins M; Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri, USA., Alderuccio JP; Sylvester Comprehensive Cancer Center, University of Miami School of Medicine, Miami, Florida, USA., Lossos IS; Sylvester Comprehensive Cancer Center, University of Miami School of Medicine, Miami, Florida, USA., Nathan S; Rush University Medical Center, Chicago, Illinois, USA., Orellana-Noia VM; Winship Cancer Institute, Emory University, Atlanta, Georgia, USA., Portell CA; Division of Hematology/Oncology, University of Virginia, Charlottesville, Virginia, USA., Landsburg DJ; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Ayers EC; Division of Hematology/Oncology, University of Virginia, Charlottesville, Virginia, USA., Castillo JJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.

المصدر: American journal of hematology [Am J Hematol] 2023 Feb; Vol. 98 (2), pp. 300-308. Date of Electronic Publication: 2023 Jan 01.

نوع المنشور: Multicenter Study; Journal Article

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Plasmablastic Lymphoma*/therapy , Plasmablastic Lymphoma*/pathology , HIV Infections*/drug therapy, Humans ; Retrospective Studies ; Neoplasm Recurrence, Local/etiology ; Antineoplastic Combined Chemotherapy Protocols ; Progression-Free Survival ; Prognosis

المؤلفون: Orellana-Noia VM; Winship Cancer Institute, Department of Hematology and Medical Oncology, Emory University, Atlanta, GA.; Division of Hematology/Oncology, University of Virginia, Charlottesville, VA., Reed DR; Division of Hematology/Oncology, University of Virginia, Charlottesville, VA.; Comprehensive Cancer Center of Wake Forest University, Section on Hematology and Oncology, Winston-Salem, NC., McCook AA; Winship Cancer Institute, Department of Biostatistics, Emory University, Atlanta, GA., Sen JM; Department of Pharmacy, University of Virginia, Charlottesville, VA., Barlow CM; Division of Hematology/Oncology, University of Virginia, Charlottesville, VA., Malecek MK; Department of Medicine, Washington University School of Medicine, St Louis, MO., Watkins M; Department of Medicine, Washington University School of Medicine, St Louis, MO., Kahl BS; Department of Medicine, Washington University School of Medicine, St Louis, MO., Spinner MA; Division of Oncology, Stanford University Medical Center, Stanford, CA., Advani R; Division of Oncology, Stanford University Medical Center, Stanford, CA., Voorhees TJ; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC.; Division of Hematology, Ohio State University, Columbus, OH., Snow A; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC., Grover NS; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC., Ayers A; Winship Cancer Institute, Department of Hematology and Medical Oncology, Emory University, Atlanta, GA., Romancik J; Winship Cancer Institute, Department of Hematology and Medical Oncology, Emory University, Atlanta, GA., Liu Y; Division of Hematology, Yale University, New Haven, CT., Huntington SF; Division of Hematology, Yale University, New Haven, CT., Chavez JC; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL., Saeed H; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL., Lazaryan A; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL., Raghunathan V; Division of Hematology and Oncology, Oregon Health Sciences University, Portland, OR.; Division of Medical Oncology, University of Washington, Seattle, WA., Spurgeon SE; Division of Hematology and Oncology, Oregon Health Sciences University, Portland, OR., Ollila TA; Division of Hematology/Oncology, Brown University, Providence, RI., Del Prete C; Division of Hematology/Oncology, Brown University, Providence, RI., Olszewski A; Division of Hematology/Oncology, Brown University, Providence, RI., Ayers EC; Division of Hematology/Oncology, University of Virginia, Charlottesville, VA.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Landsburg DJ; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Echalier B; Division of Hematology, University of Colorado, Denver, CO., Lee J; Division of Hematology, University of Colorado, Denver, CO., Kamdar M; Division of Hematology, University of Colorado, Denver, CO., Caimi PF; Adult Hematologic Malignancies and Stem Cell Transplant Section, University Hospitals Seidman Cancer Center, Cleveland, OH.; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH., Fu T; Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ., Liu J; Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ., David KA; Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ., Alharthy H; Department of Medicine, University of Maryland Medical Center, Baltimore, MD., Law J; Division of Hematology and Oncology, University of Maryland Greenbaum Comprehensive Cancer Center, Baltimore, MD., Karmali R; Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL., Shah H; University of Utah/Huntsman Cancer Institute, Salt Lake City, UT., Stephens DM; University of Utah/Huntsman Cancer Institute, Salt Lake City, UT., Major A; Section of Hematology/Oncology, University of Chicago, Chicago, IL., Rojek AE; Section of Hematology/Oncology, University of Chicago, Chicago, IL., Smith SM; Section of Hematology/Oncology, University of Chicago, Chicago, IL., Yellala A; Department of Hematology and Oncology, University of Nebraska Medical Center, Omaha, NE., Kallam A; Department of Hematology and Oncology, University of Nebraska Medical Center, Omaha, NE., Nakhoda S; Fox Chase Cancer Center, Philadelphia, PA; and., Khan N; Fox Chase Cancer Center, Philadelphia, PA; and., Sohail MA; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH., Hill BT; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH., Barrett-Campbell O; Division of Hematology and Oncology, Dartmouth Geisel School of Medicine, Hanover, NH., Lansigan F; Division of Hematology and Oncology, Dartmouth Geisel School of Medicine, Hanover, NH., Switchenko J; Winship Cancer Institute, Department of Biostatistics, Emory University, Atlanta, GA., Cohen J; Winship Cancer Institute, Department of Hematology and Medical Oncology, Emory University, Atlanta, GA., Portell CA; Division of Hematology/Oncology, University of Virginia, Charlottesville, VA.

المصدر: Blood [Blood] 2022 Jan 20; Vol. 139 (3), pp. 413-423.

نوع المنشور: Journal Article; Multicenter Study; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

مواضيع طبية MeSH: Antimetabolites, Antineoplastic/*therapeutic use , Central Nervous System Neoplasms/*prevention & control , Lymphoma, Large B-Cell, Diffuse/*prevention & control , Methotrexate/*therapeutic use , Neoplasm Recurrence, Local/*prevention & control, Adult ; Aged ; Aged, 80 and over ; Antimetabolites, Antineoplastic/administration & dosage ; Antimetabolites, Antineoplastic/adverse effects ; Female ; Humans ; Injections, Spinal ; Male ; Methotrexate/administration & dosage ; Methotrexate/adverse effects ; Middle Aged ; Retrospective Studies ; Treatment Outcome ; Young Adult

المؤلفون: Ayers EC; Division of Hematology-Oncology, Perelman Center for Advanced Medicine, University of Pennsylvania, Philadelphia, PA. Electronic address: emily.ayers@pennmedicine.upenn.edu., Margolis D; Department of Biostatistics, Epidemiology and Informatics, Perlman School of Medicine, Philadelphia, PA., Landsburg DJ; Division of Hematology-Oncology, Perelman Center for Advanced Medicine, University of Pennsylvania, Philadelphia, PA.

المصدر: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2020 Oct; Vol. 20 (10), pp. 661-667. Date of Electronic Publication: 2020 May 16.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma, Large B-Cell, Diffuse/*therapy, Adolescent ; Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Middle Aged ; Recurrence ; Retrospective Studies ; Treatment Outcome ; Young Adult

المؤلفون: Landsburg DJ; University of Pennsylvania, Philadelphia, PA, USA., Ayers EC; University of Pennsylvania, Philadelphia, PA, USA., Bond DA; The Ohio State University, Columbus, OH, USA., Maddocks KJ; The Ohio State University, Columbus, OH, USA., Karmali R; Northwestern University, Chicago, IL, USA., Behdad A; Northwestern University, Chicago, IL, USA., Curry M; Johns Hopkins University, Baltimore, MD, USA., Wagner-Johnston ND; Johns Hopkins University, Baltimore, MD, USA., Modi D; Wayne State University, Detroit, MI, USA., Ramchandren R; Wayne State University, Detroit, MI, USA.; University of Tennessee, Knoxville, TN, USA., Assouline SE; McGill University Jewish General Hospital, Montreal, QC, Canada., Faramand R; Moffitt Cancer Center, Tampa, FL, USA., Chavez JC; Moffitt Cancer Center, Tampa, FL, USA., Torka P; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Mier Hicks A; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Medeiros LJ; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Li S; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

المصدر: British journal of haematology [Br J Haematol] 2020 Apr; Vol. 189 (2), pp. 313-317. Date of Electronic Publication: 2019 Dec 05.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE

مواضيع طبية MeSH: Immunotherapy/*methods , Lymphoma, Large B-Cell, Diffuse/*drug therapy, Female ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Treatment Outcome

المؤلفون: Torka P; Roswell Park Comprehensive Cancer Center, Buffalo, NY., Kothari SK; Department of Medicine, Yale University, New Haven, CT., Sundaram S; Roswell Park Comprehensive Cancer Center, Buffalo, NY., Li S; The University of Texas MD Anderson Cancer Center, Houston, TX., Medeiros LJ; The University of Texas MD Anderson Cancer Center, Houston, TX., Ayers EC; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Landsburg DJ; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Bond DA; The Ohio State University Cancer Center, Columbus, OH., Maddocks KJ; The Ohio State University Cancer Center, Columbus, OH., Giri A; Division of Hematology and Oncology, Medical University of South Carolina, Charleston, SC., Hess B; Division of Hematology and Oncology, Medical University of South Carolina, Charleston, SC., Pham LQ; Lymphoma Division, Stanford University, Stanford, CA., Advani R; Lymphoma Division, Stanford University, Stanford, CA., Liu Y; Fox Chase Cancer Center, Philadelphia, PA., Barta SK; Fox Chase Cancer Center, Philadelphia, PA., Vose JM; University of Nebraska Medical Center, Omaha, NE., Churnetski MC; Winship Cancer Institute, Emory University, Atlanta, GA., Cohen JB; Winship Cancer Institute, Emory University, Atlanta, GA., Burkart M; Feinberg School of Medicine, Northwestern University, Chicago, IL., Karmali R; Feinberg School of Medicine, Northwestern University, Chicago, IL., Zurko J; Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL., Mehta A; Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL., Olszewski AJ; Department of Medicine, Alpert Medical School, Brown University, Providence, RI., Lee S; Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH., Hill BT; Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH., Burns TF; Dartmouth-Hitchcock Medical Center, Lebanon, NH; and., Lansigan F; Dartmouth-Hitchcock Medical Center, Lebanon, NH; and., Rabinovich E; Division of Hematology & Oncology, University of Illinois at Chicago, Chicago, IL., Peace D; Division of Hematology & Oncology, University of Illinois at Chicago, Chicago, IL., Groman A; Roswell Park Comprehensive Cancer Center, Buffalo, NY., Attwood K; Roswell Park Comprehensive Cancer Center, Buffalo, NY., Hernandez-Ilizaliturri FJ; Roswell Park Comprehensive Cancer Center, Buffalo, NY.

المصدر: Blood advances [Blood Adv] 2020 Jan 28; Vol. 4 (2), pp. 253-262.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Cytogenetics/*methods , Lymphoma, Large B-Cell, Diffuse/*genetics, Adolescent ; Adult ; Aged ; Aged, 80 and over ; Humans ; Middle Aged ; Neoplasm Staging ; Treatment Outcome ; Young Adult